COLPALNSEColgate Palmolive (India) Limited· Personal CareHighNeutral
Announced Fri, 22 May · 16:53 IST

Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Revenue DeclinePat NegativeExceptional ItemResults View source PDF

COLPAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹2158.90
prior close
₹2185.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.0-1.5-4.5-3.2-3.1-4.4-7.7-7.6-7.1-2.8-7.8-1.1
Up moveDown movePending
AI summary

Colgate-Palmolive (India) reported Q4 FY26 net sales of Rs 1,583 Crore, up 9% YoY driven by broad-based growth across portfolio. However, full-year net sales were flat at Rs 5,984 Crore vs Rs 5,999 Crore in FY25. Net profit after tax declined to Rs 1,325 Crore from Rs 1,437 Crore (-7.8%), significantly impacted by one-time inverted duty structure charges due to GST changes and lower interest income on tax refunds in the base year. The company recorded exceptional items totalling Rs 2,497 Lakhs (Rs 839 Lakhs labour code provision + Rs 1,658 Lakhs restructuring costs). EPS for the year stood at Rs 48.73 vs Rs 52.83 prior year. Auditors issued an unmodified opinion with no going concern or qualification issues. The Board declared a second interim dividend of Rs 24 per share (total Rs 48 per share for FY26), amounting to Rs 653 Crore payout.

Likely market impact

Revenue flatness and PAT decline of ~8% on full-year basis are near-term headwinds, though Q4 recovery signals improving momentum. The company remains cash-rich (Rs 1,426 Crore cash) with strong dividend payouts, providing some floor support for the stock.